(-0.88%) 4 967.23 points
(0.56%) 37 986 points
(-2.05%) 15 282 points
(0.62%) $83.24
(0.17%) $1.760
(0.36%) $2 406.70
(1.29%) $28.75
(-1.17%) $943.30
(-0.14%) $0.938
(-0.21%) $11.02
(0.56%) $0.808
(-0.95%) $93.01
Live Chart Being Loaded With Signals
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics...
Stats | |
---|---|
Today's Volume | 1.63M |
Average Volume | 808 389 |
Market Cap | 14.46B |
EPS | $0 ( 2024-02-12 ) |
Next earnings date | ( $0 ) 2024-05-09 |
Last Dividend | $0.0700 ( 2023-07-20 ) |
Next Dividend | $0 ( N/A ) |
P/E | 41.45 |
ATR14 | $3.13 (2.60%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-15 | Gonzales Anita | Buy | 248 | Common Stock |
2023-12-15 | Gonzales Anita | Buy | 706 | NQ Stock Option (right to buy) |
2023-11-27 | Michas Alexis P | Sell | 250 | Common Stock |
2023-11-28 | Michas Alexis P | Sell | 230 | Common Stock |
2023-06-15 | Gonzales Anita | Buy | 329 | Common Stock |
INSIDER POWER |
---|
28.73 |
Last 100 transactions |
Buy: 270 652 | Sell: 165 378 |
Volume Correlation
PerkinElmer Inc Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
PerkinElmer Inc Correlation - Currency/Commodity
PerkinElmer Inc Financials
Annual | 2022 |
Revenue: | $3.31B |
Gross Profit: | $1.99B (60.08 %) |
EPS: | $4.59 |
Q2 | 2023 |
Revenue: | $709.07M |
Gross Profit: | $434.50M (61.28 %) |
EPS: | $0.280 |
Q1 | 2023 |
Revenue: | $674.87M |
Gross Profit: | $381.37M (56.51 %) |
EPS: | $0.200 |
Q4 | 2022 |
Revenue: | $741.21M |
Gross Profit: | $436.33M (58.87 %) |
EPS: | $0.850 |
Financial Reports:
No articles found.
PerkinElmer Inc Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.0700 (N/A) |
$0.0700 (N/A) |
$0.0700 (N/A) |
$0.0700 (N/A) |
$0.0700 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.0225 | 1983-04-18 |
Last Dividend | $0.0700 | 2023-07-20 |
Next Dividend | $0 | N/A |
Payout Date | 2023-08-11 | |
Next Payout Date | N/A | |
# dividends | 164 | -- |
Total Paid Out | $10.25 | -- |
Avg. Dividend % Per Year | 0.11% | -- |
Score | 4.61 | -- |
Div. Sustainability Score | 9.51 | |
Div.Growth Potential Score | 4.25 | |
Div. Directional Score | 6.88 | -- |
Year | Amount | Yield |
---|---|---|
1983 | $0.0675 | 1.00% |
1984 | $0.100 | 1.24% |
1985 | $0.120 | 1.52% |
1986 | $0.130 | 1.36% |
1987 | $0.140 | 1.98% |
1988 | $0.150 | 1.78% |
1989 | $0.170 | 2.38% |
1990 | $0.190 | 2.20% |
1991 | $0.210 | 2.66% |
1992 | $0.245 | 2.03% |
1993 | $0.325 | 3.27% |
1994 | $0.280 | 3.15% |
1995 | $0.350 | 4.79% |
1996 | $0.280 | 2.35% |
1997 | $0.280 | 2.82% |
1998 | $0.280 | 2.68% |
1999 | $0.280 | 1.94% |
2000 | $0.280 | 1.35% |
2001 | $0.280 | 0.58% |
2002 | $0.280 | 0.80% |
2003 | $0.280 | 3.17% |
2004 | $0.280 | 1.60% |
2005 | $0.280 | 1.27% |
2006 | $0.280 | 1.17% |
2007 | $0.280 | 1.28% |
2008 | $0.280 | 1.10% |
2009 | $0.280 | 1.98% |
2010 | $0.280 | 1.36% |
2011 | $0.280 | 1.08% |
2012 | $0.280 | 1.36% |
2013 | $0.280 | 0.87% |
2014 | $0.280 | 0.68% |
2015 | $0.280 | 0.64% |
2016 | $0.280 | 0.53% |
2017 | $0.280 | 0.53% |
2018 | $0.280 | 0.38% |
2019 | $0.280 | 0.36% |
2020 | $0.280 | 0.28% |
2021 | $0.280 | 0.19% |
2022 | $0.280 | 0.15% |
2023 | $0.210 | 0.15% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. On the whole, the dividend outlook remains neutral, meriting close observation of both the company's financial health and growth prospects.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
SCM | Dividend King | 2023-12-15 | Monthly | 13 | 7.08% | 8.50 |
SJT | Dividend Royal | 2023-11-29 | Monthly | 39 | 12.52% | 8.50 |
ZTR | Dividend King | 2024-02-09 | Monthly | 37 | 8.35% | 8.50 |
SRV | Dividend Royal | 2023-12-04 | Monthly | 18 | 7.53% | 8.50 |
PHK | Dividend Royal | 2023-11-10 | Monthly | 22 | 6.88% | 8.50 |
JQC | Dividend Royal | 2023-11-14 | Monthly | 22 | 6.56% | 8.50 |
GOF | Dividend Royal | 2023-11-14 | Monthly | 18 | 8.03% | 8.50 |
PCF | Dividend King | 2023-12-18 | Monthly | 38 | 7.05% | 8.50 |
PVL | Dividend Royal | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.0893 | 1.500 | 8.21 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0178 | 1.200 | 9.41 | 10.00 | [0 - 0.3] |
returnOnEquityTTM | 0.0334 | 1.500 | -0.740 | -1.111 | [0.1 - 1] |
payoutRatioTTM | 0.105 | -1.000 | 8.95 | -8.95 | [0 - 1] |
currentRatioTTM | 2.58 | 0.800 | 2.11 | 1.689 | [1 - 3] |
quickRatioTTM | 1.974 | 0.800 | 3.10 | 2.48 | [0.8 - 2.5] |
cashRatioTTM | 0.974 | 1.500 | 5.70 | 8.55 | [0.2 - 2] |
debtRatioTTM | 0.317 | -1.500 | 4.72 | -7.08 | [0 - 0.6] |
interestCoverageTTM | 4.84 | 1.000 | 9.32 | 9.32 | [3 - 30] |
operatingCashFlowPerShareTTM | 2.89 | 2.00 | 9.04 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 2.41 | 2.00 | 8.79 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.573 | -1.500 | 7.71 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.585 | 1.000 | 3.59 | 3.59 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.132 | 1.000 | 9.35 | 9.35 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.0804 | 1.000 | -0.664 | -0.664 | [0.2 - 2] |
assetTurnoverTTM | 0.200 | 0.800 | -2.00 | -1.603 | [0.5 - 2] |
Total Score | 9.51 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 57.06 | 1.000 | 4.34 | 0 | [1 - 100] |
returnOnEquityTTM | 0.0334 | 2.50 | -0.476 | -1.111 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 2.41 | 2.00 | 9.20 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0.121 | 1.500 | 6.96 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 2.89 | 2.00 | 9.04 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.105 | 1.500 | 8.95 | -8.95 | [0 - 1] |
pegRatioTTM | -1.313 | 1.500 | -10.00 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.128 | 1.000 | 9.30 | 0 | [0.1 - 0.5] |
Total Score | 4.25 |
PerkinElmer Inc
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators